VGV-1

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVGV-1
Drug Alias NameThymus nuclear proteinTNPVGV-1
ClassificationBiologicsNatural product/Extract > Animal extract
Mechanisms of ActionImmunostimulantsTransmembrane glycoprotein gp41 inhibitors
TargetsTransmembrane glycoprotein gp41
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVg Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVg Life Sciences
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksDrugBank